BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 27067706)

  • 1. Randomized trial assessing home use of two pregnancy tests for determining early medical abortion outcomes at 3, 7 and 14days after mifepristone.
    Blum J; Sheldon WR; Ngoc NT; Winikoff B; Nga NT; Martin R; Van Thanh L; Blumenthal PD
    Contraception; 2016 Aug; 94(2):115-21. PubMed ID: 27067706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-administered multi-level pregnancy tests in simplified follow-up of medical abortion in Tunisia.
    Dabash R; Shochet T; Hajri S; Chelli H; Hassairi AE; Haleb D; Labassi H; Sfar E; Temimi F; Koenig L; Winikoff B
    BMC Womens Health; 2016 Jul; 16():49. PubMed ID: 27475998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial multilevel urine pregnancy testing to assess medical abortion outcome: a meta-analysis.
    Raymond EG; Shochet T; Blum J; Sheldon WR; Platais I; Bracken H; Dabash R; Weaver MA; Ngoc NTN; Blumenthal PD; Winikoff B
    Contraception; 2017 May; 95(5):442-448. PubMed ID: 28041991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of an at-home multilevel pregnancy test and an automated call-in system to follow-up the outcome of medical abortion.
    Anger H; Dabash R; Peña M; Coutiño D; Bousiéguez M; Sanhueza P; Winikoff B
    Int J Gynaecol Obstet; 2019 Jan; 144(1):97-102. PubMed ID: 30221366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-assessment of medical abortion outcome using symptoms and home pregnancy testing.
    Raymond EG; Tan YL; Grant M; Benavides E; Reis M; Sacks DN; Hannum C; Frapp S; Weaver MA
    Contraception; 2018 Apr; 97(4):324-328. PubMed ID: 29242085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of self-performed urine pregnancy testing for follow-up after medical abortion.
    Hassoun D; Périn I; Hiên H; Demars HH
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():174-8. PubMed ID: 26773308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum human chorionic gonadotropin (hCG) trend within the first few days after medical abortion: a prospective study.
    Pocius KD; Bartz D; Maurer R; Stenquist A; Fortin J; Goldberg AB
    Contraception; 2017 Mar; 95(3):263-268. PubMed ID: 27621046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can at-home semi-quantitative pregnancy tests serve as a replacement for clinical follow-up of medical abortion? A US study.
    Blum J; Shochet T; Lynd K; Lichtenberg ES; Fischer D; Arnesen M; Winikoff B; Blumenthal PD
    Contraception; 2012 Dec; 86(6):757-62. PubMed ID: 22895097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a pilot study in the U.S. and Vietnam to assess the utility and acceptability of a multi-level pregnancy test (MLPT) for home monitoring of hCG trends after assisted reproduction.
    Shochet T; Comstock IA; Ngoc NTN; Westphal LM; Sheldon WR; Loc LT; Blum J; Winikoff B; Blumenthal PD
    BMC Womens Health; 2017 Aug; 17(1):67. PubMed ID: 28830483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of telephone follow-up after medical abortion.
    Perriera LK; Reeves MF; Chen BA; Hohmann HL; Hayes J; Creinin MD
    Contraception; 2010 Feb; 81(2):143-9. PubMed ID: 20103453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
    Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of misoprostol-only and combined mifepristone-misoprostol regimens for home-based early medical abortion in Tunisia and Vietnam.
    Blum J; Raghavan S; Dabash R; Ngoc Nt; Chelli H; Hajri S; Conkling K; Winikoff B
    Int J Gynaecol Obstet; 2012 Aug; 118(2):166-71. PubMed ID: 22682768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simplified medical abortion using a semi-quantitative pregnancy test for home-based follow-up.
    Lynd K; Blum J; Ngoc NT; Shochet T; Blumenthal PD; Winikoff B
    Int J Gynaecol Obstet; 2013 May; 121(2):144-8. PubMed ID: 23477704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: evidence from Uzbekistan.
    Raghavan S; Tsereteli T; Kamilov A; Kurbanbekova D; Yusupov D; Kasimova F; Jymagylova D; Winikoff B
    Eur J Contracept Reprod Health Care; 2013 Apr; 18(2):104-11. PubMed ID: 23387475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
    Faucher P; Baunot N; Madelenat P
    Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assessment of the outcome of early medical abortion versus clinic follow-up in India: a randomised, controlled, non-inferiority trial.
    Iyengar K; Paul M; Iyengar SD; Klingberg-Allvin M; Essén B; Bring J; Soni S; Gemzell-Danielsson K
    Lancet Glob Health; 2015 Sep; 3(9):e537-45. PubMed ID: 26275330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria.
    Okonofua F; Shittu O; Shochet T; Diop A; Winikoff B
    Int J Gynaecol Obstet; 2014 Apr; 125(1):49-52. PubMed ID: 24507887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical abortion in the first trimester: the use of serum hCG and endometrial thickness as markers of completeness.
    Parashar P; Iversen OE; Midbøe G; Myking O; Bjørge L
    Eur J Contracept Reprod Health Care; 2007 Dec; 12(4):366-71. PubMed ID: 17853164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical abortion outcomes after a second dose of misoprostol for persistent gestational sac.
    Reeves MF; Kudva A; Creinin MD
    Contraception; 2008 Oct; 78(4):332-5. PubMed ID: 18847584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.